Details for Patent: 11,286,488
✉ Email this page to a colleague
Which drugs does patent 11,286,488 protect, and when does it expire?
Patent 11,286,488 protects RIVFLOZA and is included in one NDA.
This patent has nineteen patent family members in fourteen countries.
Summary for Patent: 11,286,488
| Title: | Methods and compositions for inhibiting expression of LDHA |
| Abstract: | This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes. |
| Inventor(s): | Brown Bob D., Dudek Henryk T., Saxena Utsav, Pursell Natalie, Lai Cheng, Wang Weimin, Storr Rachel, Nazef Naim, Kim Boyoung |
| Assignee: | Dicerna Pharmaceuticals, Inc. |
| Application Number: | US16755342 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,286,488
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-001 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Try a Trial | ||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-002 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Try a Trial | ||
| Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-003 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,286,488
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018346971 | ⤷ Try a Trial | |||
| Canada | 3078933 | ⤷ Try a Trial | |||
| China | 111448319 | ⤷ Try a Trial | |||
| European Patent Office | 3679141 | ⤷ Try a Trial | |||
| European Patent Office | 4265261 | ⤷ Try a Trial | |||
| Spain | 2955045 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
